Literature DB >> 8095417

Central alpha 2-autoreceptors: agonist dissociation constants and recovery after irreversible inactivation.

E Agneter1, H Drobny, E A Singer.   

Abstract

1. Rats received an intraperitoneal injection of 1.6 mg kg-1 N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) to achieve an irreversible inactivation of presynaptic release-modulating alpha 2-autoreceptors. Cerebral cortex slices were prepared at different times after the injection (24, 48, 96, 192, 336, 774 h), incubated with [3H]-noradrenaline ([3H]-NA), superfused and stimulated electrically with 4 pulses at 100 Hz (= autoinhibition-free condition). Overflow of radioactivity was used to measure release. Furchgott analysis was used to estimate agonist dissociation constants (KA) and pool size of resynthesized receptors (q). 2. The KA values of the three alpha 2-autoreceptor agonists, bromoxidine (UK-14304), clonidine and noradrenaline (NA) were 187 nM, 72 nM, and 1202 nM, respectively. 3. The release-inhibiting effects of the agonists returned considerably faster than the receptor pool. The calculated half-lives for the recovery of the maximal release-inhibiting effects of bromoxidine, clonidine and NA were 30.7, 63.6 and 20.8 h, respectively, whereas the half-life for the recovery of the receptor pool was 445 h. 4. The data indicate a large receptor reserve at presynaptic alpha 2-autoreceptors for the agonists used and validate the use of EEDQ as a tool for the determination of agonist dissociation constants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095417      PMCID: PMC1907994          DOI: 10.1111/j.1476-5381.1993.tb12811.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?

Authors:  P Leff; I G Dougall; D H Harper; I A Dainty
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

2.  Graphical and weighted regression analyses for the determination of agonist dissociation constants.

Authors:  C D Thron
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

3.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

4.  Measurement of alpha-adrenoceptor "turnover' using phenoxybenzamine.

Authors:  R M McKernan; I C Campbell
Journal:  Eur J Pharmacol       Date:  1982-05-21       Impact factor: 4.432

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Review important concepts of receptor theory.

Authors:  R R Ruffolo
Journal:  J Auton Pharmacol       Date:  1982-12

7.  Estimation of pA2 values at presynaptic alpha 2-autoreceptors in rabbit and rat brain cortex in the absence of autoinhibition.

Authors:  N Limberger; A Mayer; G Zier; B Valenta; K Starke; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

8.  N-carboxylic acid esters of 1,2- and 1,4-dihydroquinolines. A new class of irreversible inactivators of the catecholamine alpha receptors and potent central nervous system depressants.

Authors:  B Belleau; R Martel; G Lacasse; M Ménard; N L Weinberg; Y G Perron
Journal:  J Am Chem Soc       Date:  1968-01-31       Impact factor: 15.419

9.  N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo.

Authors:  A Pilc; G Nowak; J Zak
Journal:  Eur J Pharmacol       Date:  1992-02-25       Impact factor: 4.432

10.  Characteristics and metabolism of alpha 1 adrenergic receptors in a nonfusing muscle cell line.

Authors:  J P Mauger; F Sladeczek; J Bockaert
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

View more
  2 in total

1.  New insights into receptor theory, as provided by an artificial partial agonist made-to-measure.

Authors:  T J Feuerstein; W Sauermann; C Allgaier; E Agneter; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

2.  Covariation of alpha 2-adrenoceptor density and function following irreversible antagonism with EEDQ.

Authors:  M J Durcan; P F Morgan; M L Van Etten; M Linnoila
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.